Belluscura26 Sep 2023 07:15
Excellent news from Bell to say the least.
Belluscura plc
("Belluscura" or the "Company")
Belluscura Receives Approval and First Purchase Order in Hong Kong and commences the manufacture of the first DISCOV-R(TM) units
Belluscura secures its first approval in phase one of its exclusive license agreement with Innomax Licensing Agreement
LONDON, U.K. and PLANO, TX, U.S. (26 September 2023). Belluscura plc (AIM:BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has received approval from the Hong Kong Department of Health - Medical Device Division to distribute the X-PLOR(R) portable oxygen concentrator.
Belluscura has already received its first purchase order from a Hong Kong distributor. Hong Kong is part of the licensed territory in its Exclusive License Agreement signed last month with Innomax Medical Device Technologies.
The Company is also pleased to announce the successful completion of the DISCOV-R(TM) portable oxygen concentrator patient usability study with all participants providing favorable feedback on the device. Initial production of the DISCOV-R(TM) will commence this week. Full-scale production is being planned in conjunction with Innomax in response to the significant preliminary demand already received by the Company.